Literature DB >> 32033856

Overprescribing of Opioids to Adults by Dentists in the U.S., 2011-2015.

Katie J Suda1, Jifang Zhou2, Susan A Rowan3, Jessina C McGregor4, Rosanne I Perez5, Charlesnika T Evans6, Walid F Gellad7, Gregory S Calip8.   

Abstract

INTRODUCTION: Dentists prescribe 1 in 10 opioid prescriptions in the U.S. When opioids are necessary, national guidelines recommend the prescription of low-dose opioids for a short duration. This study assesses the appropriate prescribing of opioids by dentists before guideline implementation.
METHODS: The authors performed a cross-sectional analysis of a population-based sample of 542,958 U.S. commercial dental patient visits between 2011 and 2015 within the Truven Health MarketScan Research Databases (data analysis October 2018‒April 2019). Patients with recent hospitalization, active cancer treatment, or chronic pain conditions were excluded. Prescription opioids were ascertained using pharmacy claims data with standardized morphine equivalents and recorded days' supply. Appropriate prescribing was determined from the 2016 Centers for Disease Control and Prevention guidelines for pain management based on a recommended 3 days' supply of opioid medication and anticipated post-procedural pain.
RESULTS: Twenty-nine percent of prescribed opioids exceeded the recommended morphine equivalents for appropriate management of acute pain. Approximately half (53%) exceeded the recommended days' supply. Patients aged 18-34 years, men, patients residing in the Southern U.S., and those receiving oxycodone were most likely to have opioids prescribed inappropriately. The proportion of opioids that exceed the recommended morphine equivalents increased over the study period, whereas opioids exceeding the recommended days' supply remained unchanged.
CONCLUSIONS: Between 1 in 4 and 1 in 2 opioids prescribed to adult dental patients are overprescribed. Judicious opioid-prescribing interventions should be tailored to oral health conditions and dentists. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32033856     DOI: 10.1016/j.amepre.2019.11.006

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  12 in total

1.  Distribution of Opioid Prescribing and High-Risk Prescribing Among U.S. Dentists in 2019.

Authors:  Kao-Ping Chua; Jennifer F Waljee; Vidhya Gunaseelan; Romesh P Nalliah; Chad M Brummett
Journal:  Am J Prev Med       Date:  2022-03       Impact factor: 5.043

2.  Trends in Opioid Prescribing by General Dentists and Dental Specialists in the U.S., 2012-2019.

Authors:  Connie H Yan; Todd A Lee; Lisa K Sharp; Colin C Hubbard; Charlesnika T Evans; Gregory S Calip; Susan A Rowan; Jessina C McGregor; Walid F Gellad; Katie J Suda
Journal:  Am J Prev Med       Date:  2022-02-26       Impact factor: 6.604

Review 3.  Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.

Authors:  Keith Humphreys; Chelsea L Shover; Christina M Andrews; Amy S B Bohnert; Margaret L Brandeau; Jonathan P Caulkins; Jonathan H Chen; Mariano-Florentino Cuéllar; Yasmin L Hurd; David N Juurlink; Howard K Koh; Erin E Krebs; Anna Lembke; Sean C Mackey; Lisa Larrimore Ouellette; Brian Suffoletto; Christine Timko
Journal:  Lancet       Date:  2022-02-02       Impact factor: 202.731

4.  Association Between Medicaid Prescription Drug Limits and Access to Medications and Health Care Use Among Young Adults With Disabilities.

Authors:  Caroline K Geiger; Jessica L Cohen; Benjamin D Sommers
Journal:  JAMA Health Forum       Date:  2021-06-17

5.  Prescription and Prescriber Specialty Characteristics of Initial Opioid Prescriptions Associated with Chronic Use.

Authors:  Scott G Weiner; Shih-Chuan Chou; Cindy Y Chang; Chad Garner; Sanae El Ibrahimi; Sara Hallvik; Michelle Hendricks; Olesya Baker
Journal:  Pain Med       Date:  2020-12-25       Impact factor: 3.750

6.  Opioid prescribing patterns by dental procedure among US publicly and privately insured patients, 2013 through 2018.

Authors:  Kao-Ping Chua; Hsou-Mei Hu; Jennifer F Waljee; Chad M Brummett; Romesh P Nalliah
Journal:  J Am Dent Assoc       Date:  2021-02-23       Impact factor: 3.634

7.  Dental Opioid Prescriptions and Overdose Risk in Patients and Their Families.

Authors:  Kao-Ping Chua; Brooke C Kenney; Jennifer F Waljee; Chad M Brummett; Romesh P Nalliah
Journal:  Am J Prev Med       Date:  2021-04-29       Impact factor: 6.604

8.  Persistent Opioid Use Associated With Dental Opioid Prescriptions Among Publicly and Privately Insured US Patients, 2014 to 2018.

Authors:  Kao-Ping Chua; Hsou-Mei Hu; Jennifer F Waljee; Romesh P Nalliah; Chad M Brummett
Journal:  JAMA Netw Open       Date:  2021-04-01

9.  Changes in Prescribing by Provider Type Following a State Prescription Opioid Restriction Law.

Authors:  Ivelisse L Valdes; Marie-Christin Possinger; Juan M Hincapie-Castillo; Amie J Goodin; Marvin A Dewar; Jill M Sumfest; Scott M Vouri
Journal:  J Gen Intern Med       Date:  2021-07-08       Impact factor: 6.473

10.  Pain Management for Dental Medicine in 2021: Opioids, Coronavirus and Beyond.

Authors:  Steven J Scrivani; David A Keith; Ronald J Kulich; Alexandre F DaSilva; R Bruce Donoff; Shruti Handa; Nicole Holland; Mark A Lerman; Jenna L McCauley; Lori Reisner; Cory M Resnick; Christian S Stohler; Alexis Vasciannie; Matthew Fortino; Michael E Schatman
Journal:  J Pain Res       Date:  2021-05-24       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.